| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13,952 |
12,698 |
$293K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
14,603 |
13,661 |
$288K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,162 |
5,098 |
$104K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,067 |
4,524 |
$95K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,862 |
4,373 |
$92K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
468 |
322 |
$26K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
776 |
694 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
797 |
285 |
$12K |
| 87660 |
|
1,098 |
897 |
$12K |
| 87510 |
|
1,104 |
901 |
$12K |
| 87480 |
|
1,082 |
883 |
$12K |
| 88342 |
|
662 |
556 |
$11K |
| 87481 |
|
707 |
483 |
$10K |
| 88141 |
|
261 |
196 |
$3K |
| 88341 |
|
147 |
110 |
$3K |
| 81513 |
|
122 |
107 |
$2K |
| 87529 |
|
118 |
66 |
$2K |
| 87640 |
|
70 |
68 |
$1K |
| 87563 |
|
88 |
85 |
$839.62 |
| 88142 |
|
45 |
42 |
$682.26 |
| 88312 |
|
35 |
27 |
$554.96 |
| 88304 |
|
37 |
36 |
$355.43 |
| 88112 |
|
17 |
13 |
$153.28 |
| 87511 |
|
18 |
17 |
$140.06 |